Elevated Capital Advisors, LLC Amgen Inc Transaction History

Elevated Capital Advisors, LLC

$340 Million
Q3 2024

A detailed history of Elevated Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Elevated Capital Advisors, LLC holds 1,539 shares of AMGN stock, worth $453,281. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,539

Previous 1,501 2.53%

Holding current value

$453,281

Previous $468,000 5.77%

% of portfolio

0.15%

Previous 0.14%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $11,756 - $12,820	38 Added 2.53%	1,539 $495,000
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $45,455 - $55,240	173 Added 13.03%	1,501 $468,000
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $26,349 - $31,806	98 Added 7.97%	1,328 $377,000
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $29,149 - $32,884	114 Added 10.22%	1,230 $354,000
Q3 2023 Oct 17, 2023	SELL	$218.65 - $271.46 $4,373 - $5,429	-20 Reduced 1.76%	1,116 $299,000
Q2 2023 Aug 18, 2023	BUY	$214.27 - $253.37 $28,712 - $33,951	134 Added 13.37%	1,136 $252,000
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $12,644 - $15,411	56 Added 5.92%	1,002 $242,000
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $216,662 - $275,295	946 New	946 $0
Q2 2020 Sep 11, 2020	SELL	$197.81 - $242.74 $205,920 - $252,692	-1,041 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $294,599 - $378,662	-1,557 Reduced 59.93%	1,041 $251,000
Q1 2019 Apr 16, 2020	BUY	$180.87 - $203.88 $469,900 - $529,680	2,598 New	2,598 $576,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Elevated Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elevated Capital Advisors, LLC with notifications on news.

Account

Elevated Capital Advisors, LLC Amgen Inc Transaction History